Christopher Yea, CHIEF DEVELOPMENT OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 23,220 shares at $11.76 ($273K) on 2024-05-20, disclosed to the SEC on 2024-05-21.
Open-market sale of $273k KALV by CHIEF DEVELOPMENT OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.76 | 11,610 | $137K | 50.0% |
| 2 | $11.76 | 11,610 | $137K | 50.0% |
| Total | $11.76 avg | 23,220 | $273K | 100% |
| Filing → |
| KALV | SELL | 2026-05-26 | $63K | — | Filing → |
| KALV | SELL | 2026-05-19 | $30K | — | Filing → |
| KALV | SELL | 2026-02-24 | $68K | — | Filing → |